5.1 - Analgesics - Non-Narcotic Flashcards

1
Q

Analgesics

A
  • Non-narcotic

* Narcotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Non-narcotic

A
  • Nociceptive
    • Somatic
    • Visceral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Narcotic

A

Psychogenic/ Affective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Para-amino Phenols

A
  • Phenacitin

* Paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
– Active form: Paracetamol
– ✖️ used anymore
   - ⬆️ risk of Urinary Tract Cancer
   - ⬆️ risk of acute renal failure
   - methemoglobinemia
A

Phenacitin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

– Weak inhibitor of PG synthesis

A

Paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Paracetamol aka:

A

– Acetaminophen
– APAP
– Acetyl-p-aminophenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Uses: PARACETAMOL

— Safe to give during pregnancy/ lactation

A

• Analgesic
- Mgt of MILD pain
- 1st line: Mgt if Osteoarthritis
• Antipyretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

S/E: PARACETAMOL

A

• Mild transaminitis
• SJS-TEN
— SJS: 10% TEN: >30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Toxicity: PARACETAMOL

A

• Hepatic necrosis

- > 150mg/ kg/ day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Maximum Daily Dose: PARACETAMOL

A

Nmt 4 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolism: PARACETAMOL

A
• Glucuronidation (65%)
• Sulfation (30%)
• Oxidation (5%)
 – CYP1A2
  – NAPQI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NSAIDs

— All are WEAK organic acids ✖️ Nabumetone

A

MOA: Inhibition of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2 Types of COX

A
  • COX 1

* COX 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

– Constitutive enzyme
– produced by most cells as part of their function
– synthesis of PGs with maintenance functions
- cytoprotection
- vasodilation

A

COX 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

– Inducible Enzyme
– found in immune cells
– Produced in the setting of inflammation

A

COX 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

‼️‼️‼️

In ENDOTHELIAL cells, COX 2 is constitutive

A

– synthesis of PGI2 & PGE 2

- Anti-agreggants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NSAIDs

A

– Nonselective COX inhibitors

– Selective/ Specifix COX2 Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Non-narcotic

A
  • Para-amino phenols

* NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nonselective COX Inhibitors

A
  • ASA & Salicylates
  • Pyrazole Derivatives
  • Pyrrole alkanoic acid derivative
  • Indole derivatives
  • Fenamates
  • Oxicam Derivatives
  • Phenyl acetic acid derivatives
  • Propionic Acid derivatives
19
Q

ASA & Salicylates

A
  • Pharmacokinetics
  • Pharmacodynamics
  • S/E
20
Q

Pharmacokinetics

A
  • Absorption

* Excretion

21
Q

Absorption

A

– Stomach

– Upper part of the SI

22
Q

Elimination

A

– < 600 mg/ day (1st order)

– > 600 mg/ day (zero order)

23
Pharmacodynamics
* Analgesic * Anti-inflammatory * Anti-pyretic * Antiplatelet * Anticancer
24
Analgesic | — NMT 600 mg/ day
* Peripheral: ✖️PG synthesis | * Central: ✖️ Pain perception in the subcortical sites
25
Anti-inflammatory | — 3.2-4 g/ day
– ✖️ PG synthesis | – ✖️Chemotaxis — cell movement
26
Anti-pyretic — 0.3-2.4 g/ day — 0.3-1.2 g/ day
– ✖️ of response to endogenous pyrogens (interleukin 1) — Central – induces cutaneous vasodilation — Peripheral
27
Antiplatelet | — NMT 325 mg/ day
– Irreversible acetylation (inhibition) of COX in platelets — TXA2 synthesis – ⬇️ dose = ⬆️ Antiplatelet effect
28
Anticancer | — Potential
Reduction of colonic polyps
29
S/E
* GI S/E * Renal * Effdct on serum urate level * CNS Effects * Hypersensitivity reactions * Reye's Syndrome
30
S/E: NON SELECTIVE COX
* GI Intolerance | * Gastritis
31
– Hyperacidity/ dyspepsia – ✖️ mucosal injury – Prevention: Intake of NSAIDs after a FULL meal
GI Intolerance
32
``` – ✔️ mucosal injury – Prevention: - PPIs - H2 blockers - Misoprostol ```
Gastritis
33
Risk Factors: NSAID-INDUCED GASTRITIS
- Advanced Age - ⬆️ dose NSAIDs - Multiple NSAID use - History of PUD - Concomittant use of Corticosteroids - Critical illness
34
Renal S/E: ALL NSAIDs
⬇️ GFR = reversible | — afferent arteriole - constriction
35
‼️‼️‼️
* * NSAIDs nay predisppse pts with pre-existing renal disease to acute rena failure * * NSAIDs ⬇️⬇️ the effects of Diuretics
36
Effect on serum urate level | — C/I: Gout
``` • Aspirin – < 2 g/ day: Hyperuricemia • Salicylates – > 4 g/ day: Uricosurin • Tolmetin ```
37
CNS S/E
* Serum Level | * Clinical Manifestation
38
50-80 mg/ dL
``` • Salicylism - tinnitus - ⬇️ hearing - vertigo • Respiratory ALKALOSIS • Hyperventilation ```
39
80-110 mg/ dL
* Metabolic ACIDOSIS * Hyperthermia * Dehydration
40
110-160 mg/ dL
Hypoprothrombinemia | Bleeding
41
> 160 mg/ dL
Respiratory/ Renal Failure
42
Hypersensitivity Rxn: ALL NSAIDs
NSAID-induced bronchial asthma
43
Reye's Syndrome
• ASA + suring/ after a recent viral infection - hepatic failure - encephalopathy
44
Pyrazolone Derivatives — Anti inflammatory — Analgesic
* PhenylbutazONE * DipyrONE * SulfinoyrazONE
45
– ✖️ NSAID – Uricosuric — tx of gout
Sulfinpyrazone
46
A/E: PYRAZOLONE DERIVATIVES
* Hematotoxocities | * Nephrotoxicities
47
Hematotoxicities
* Agranulocytosis * Aplastic anemia * Theombocytopenia